Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.

Ho RX, Meyer RD, Chandler KB, Ersoy E, Park M, Bondzie PA, Rahimi N, Xu H, Costello CE, Rahimi N.

J Mol Cell Biol. 2018 Jun 1;10(3):195-204. doi: 10.1093/jmcb/mjy002.

PMID:
29329397
2.

Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.

Chandler KB, Leon DR, Meyer RD, Rahimi N, Costello CE.

J Proteome Res. 2017 Feb 3;16(2):677-688. doi: 10.1021/acs.jproteome.6b00738. Epub 2016 Dec 29.

3.

Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Villar RF, Patel J, Weaver GC, Kanekiyo M, Wheatley AK, Yassine HM, Costello CE, Chandler KB, McTamney PM, Nabel GJ, McDermott AB, Mascola JR, Carr SA, Lingwood D.

Sci Rep. 2016 Oct 31;6:36298. doi: 10.1038/srep36298.

4.

Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities.

Chandler KB, Costello CE.

Electrophoresis. 2016 Jun;37(11):1407-19. doi: 10.1002/elps.201500552. Epub 2016 Mar 29. Review.

5.

Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4.

Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.

J Proteome Res. 2014 Jul 3;13(7):3314-29. doi: 10.1021/pr500394z. Epub 2014 Jun 12.

6.

Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search.

Chandler KB, Pompach P, Goldman R, Edwards N.

J Proteome Res. 2013 Aug 2;12(8):3652-66. doi: 10.1021/pr400196s. Epub 2013 Jul 22.

7.

N-glycans in liver-secreted and immunoglogulin-derived protein fractions.

Bekesova S, Kosti O, Chandler KB, Wu J, Madej HL, Brown KC, Simonyan V, Goldman R.

J Proteomics. 2012 Apr 3;75(7):2216-24. doi: 10.1016/j.jprot.2012.01.024. Epub 2012 Feb 3.

8.

Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search.

Pompach P, Chandler KB, Lan R, Edwards N, Goldman R.

J Proteome Res. 2012 Mar 2;11(3):1728-40. doi: 10.1021/pr201183w. Epub 2012 Feb 6.

9.

Cadmium effects on transcriptional expression of rhlB/rhlC genes and congener distribution of monorhamnolipid and dirhamnolipid in Pseudomonas aeruginosa IGB83.

Neilson JW, Zhang L, Veres-Schalnat TA, Chandler KB, Neilson CH, Crispin JD, Pemberton JE, Maier RM.

Appl Microbiol Biotechnol. 2010 Oct;88(4):953-63. doi: 10.1007/s00253-010-2808-8. Epub 2010 Aug 13.

PMID:
20706835
10.

Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold.

Ballet S, Mayorov AV, Cai M, Tymecka D, Chandler KB, Palmer ES, Rompaey KV, Misicka A, Tourwé D, Hruby VJ.

Bioorg Med Chem Lett. 2007 May 1;17(9):2492-8. Epub 2007 Feb 9.

11.

Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Mayorov AV, Cai M, Chandler KB, Petrov RR, Van Scoy AR, Yu Z, Tanaka DK, Trivedi D, Hruby VJ.

J Med Chem. 2006 Mar 23;49(6):1946-52.

12.

Forced eruption: review and case reports.

Chandler KB, Rongey WF.

Gen Dent. 2005 Jul-Aug;53(4):274-7.

PMID:
16158796
13.

Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.

Catapano CV, Chandler KB, Fernandes DJ.

Cancer Res. 1991 Apr 1;51(7):1829-35.

Supplemental Content

Loading ...
Support Center